These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5853691)

  • 1. The in vivo production of a potent, long-acting hypotensive metabolite from diallylmelamine.
    Zins GR
    J Pharmacol Exp Ther; 1965 Oct; 150(1):109-17. PubMed ID: 5853691
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypotensive metabolite production and sequential metabolism of N,N-diallylmelamine in rats, dogs and man.
    Zins GR; Emmert DE; Walk RA
    J Pharmacol Exp Ther; 1968 Jan; 159(1):194-205. PubMed ID: 5689401
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism of 3,5-dimethylpyrazole-C14 in the rat.
    Smith DL; Forist AA; Gerritsen GC
    J Pharmacol Exp Ther; 1965 Nov; 150(2):316-21. PubMed ID: 5855887
    [No Abstract]   [Full Text] [Related]  

  • 4. [Catapressan metabolism. Hypotensive effect of 4-hydroxycatapressan].
    Ehrhardt JD
    Therapie; 1972; 27(5):947-54. PubMed ID: 4651414
    [No Abstract]   [Full Text] [Related]  

  • 5. The nature of the metabolites of acetohexamide in the rat and in the human.
    McMahon RE; Marshall FJ; Culp HW
    J Pharmacol Exp Ther; 1965 Aug; 149(2):272-9. PubMed ID: 5831048
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemical and pharmacological properties of urotensin I, a long acting mammalian hypotensive peptide.
    Lederis K
    Acta Physiol Lat Am; 1974; 24(5):481-3. PubMed ID: 4467676
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of preexperimental blood pressure level on hypotensive responses to vasodilator drugs.
    Serrano JS; Pelayo F; Tamargo JL; García De Jalón PD
    Arch Farmacol Toxicol; 1975 Aug; 1(2):91-8. PubMed ID: 1230033
    [No Abstract]   [Full Text] [Related]  

  • 8. [Search for pyridazine derivatives with hypotensive action].
    Bałoniak S; Drozdzyńska E; Linkowska E; Mroczkiewicz MF; Oledzka K; Zyczyńska-Bałoniak I
    Acta Pol Pharm; 1979; 36(3):295-300. PubMed ID: 517146
    [No Abstract]   [Full Text] [Related]  

  • 9. Calcitonin gene-related peptide-mediated antihypertensive and anti-platelet effects by rutaecarpine in spontaneously hypertensive rats.
    Li D; Peng J; Xin HY; Luo D; Zhang YS; Zhou Z; Jiang DJ; Deng HW; Li YJ
    Peptides; 2008 Oct; 29(10):1781-8. PubMed ID: 18625276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synthesis of selected amines with potential hypotensive effects].
    Gutkowska B; Rogala-Zawadzka G
    Acta Pol Pharm; 1988; 45(4):297-300. PubMed ID: 3245469
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemical and pharmacological study of new derivatives of noradrenaline].
    Régnier G; Canevari R; Laubie M; Le Douarec JC
    Arzneimittelforschung; 1969 Oct; 19(10):1698-702. PubMed ID: 5395370
    [No Abstract]   [Full Text] [Related]  

  • 12. Tissue distribution and hypotensive effects of minoxidil in normotensive rats.
    Pluss RG; Orcutt J; Chidsey CA
    J Lab Clin Med; 1972 Apr; 79(4):639-47. PubMed ID: 5021302
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular effects of a novel vasoactive antihypertensive agent, Ro 12-4713.
    Gerold M; Eigenmann R; Hefti F; Daum A; Haeusler G
    J Pharmacol Exp Ther; 1981 Mar; 216(3):624-33. PubMed ID: 7009831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The absorption, distribution and elimination of nevadensin in the rat, and the relationship between plasma concentration of the drug and its hypotensive effect].
    Han GZ; Su CY; Zhang Y
    Yao Xue Xue Bao; 1982 Aug; 17(8):572-8. PubMed ID: 7180490
    [No Abstract]   [Full Text] [Related]  

  • 15. [The chemistry and pharmacology of flavonoid fractions with a hypotensive effect isolated from wild geraniums].
    Petkov V; Ivancheva S; Ognianov I; Tsonev I; Raĭnova L
    Eksp Med Morfol; 1972; 11(2):45-54. PubMed ID: 4681184
    [No Abstract]   [Full Text] [Related]  

  • 16. The hypotensive effect of dauricine and its mechanism of action.
    Chen SH; Hu CJ
    Acta Acad Med Wuhan; 1983; 3(2):125-7. PubMed ID: 6866387
    [No Abstract]   [Full Text] [Related]  

  • 17. Antihypertensive effects of the novel potassium channel activator SKP-450 and its major metabolites in rats.
    Shin HS; Seo HW; Oh JH; Lee BH
    Arzneimittelforschung; 1998 Oct; 48(10):969-78. PubMed ID: 9825113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption, distribution & excretion of scoparone: a potent hypotensive agent.
    Zutshi U; Rao PG; Soni A; Atal CK
    Indian J Exp Biol; 1978 Jul; 16(7):836-8. PubMed ID: 700833
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypotensive activity of novokinin, a potent analogue of ovokinin(2-7), is mediated by angiotensin AT(2) receptor and prostaglandin IP receptor.
    Yamada Y; Yamauchi D; Usui H; Zhao H; Yokoo M; Ohinata K; Iwai M; Horiuchi M; Yoshikawa M
    Peptides; 2008 Mar; 29(3):412-8. PubMed ID: 18207609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolism of ethyl 4-(3,4,5-Trimethoxycinnamoyl) piperazinyl acetate in rats and dogs.
    Chasseaud LF; Hawkins DR; Fry BJ; Lewis JD; Moore DH; Taylor T; Hathway DE
    Arzneimittelforschung; 1972 Oct; 22(10):1726-32. PubMed ID: 4197737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.